Comparison of epigenetic versus standard induction chemotherapy for newly diagnosed acute myeloid leukemia patients ≥60 years old

Older patients with acute myeloid leukemia (AML) have poor outcomes with standard induction chemotherapy. We retrospectively reviewed our institute’s experience with epigenetic (Epi) versus cytarabine- and anthracycline-based intensive chemotherapy (IC) as induction in newly diagnosed AML patients a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Hematol
Main Authors: Gupta, Neha, Miller, Austin, Gandhi, Shipra, Ford, Laurie A., Vigil, Carlos E., Griffiths, Elizabeth A., Thompson, James E., Wetzler, Meir, Wang, Eunice S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6791130/
https://ncbi.nlm.nih.gov/pubmed/25808347
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.24016
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados